Literature DB >> 28762263

Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1.

S S Iyengar1, Raman Puri2, S N Narasingan3, S K Wangnoo4, V Mohan5, J C Mohan6, Anoop Misra7, Usha Sriram8, Jamshed J Dalal9, Rajeev Gupta10, D Prabhakar11, Prafulla Kerkar12, Abdul Hamid Zargar13, Ravi R Kasliwal14, Rahul Mehrotra15, Soumitra Kumar16, Rabin Chakraborty17, Manoj Chadha18, Mradul Kumar Daga19, Krishna Seshadri20, Justin Paul21, Narasaraju Kavalipati22, Dheeraj Kapoor23, V S Narain24, Ashu Rastogi25, A Muruganathan26, Ajay Gupta27, S Murthy28, Neil Bordoloi29, Prasant Kumar Sahoo30, Rajesh Kumar Agarwal31, Milan Chag32, Rajesh Rajput33, Rashida Patanwala Melinkeri34.   

Abstract

Entities:  

Year:  2016        PMID： 28762263

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  9 in total

1.  Implications of the 2013 ACC/AHA cholesterol guidelines on contemporary clinical practice for patients with atherosclerotic coronary and peripheral arterial disease.

Authors:  Prasad Gunasekaran; Vinodh Jeevanantham; Suresh Sharma; Rashmi Thapa; Kamal Gupta
Journal:  Indian Heart J       Date:  2017-05-22

2.  Yoga as a Preventive Intervention for Cardiovascular Diseases and Associated Comorbidities: Open-Label Single Arm Study.

Authors:  Kaushal Sharma; Indranill Basu-Ray; Natasha Sayal; Ariana Vora; Sridhar Bammidi; Rahul Tyagi; Shweta Modgil; Parul Bali; Paramvir Kaur; Atul Kumar Goyal; Deepak Kumar Pal; Harshita Arvind; Khushboo Jindal; Vincy Garg; Bandu Matyal; Neha Thakur; Amit Chhikara; Navneet Kaur; Preety Maanju; Kulsajan Singh Bhatia; Viraaj Pannu; Vanita Gupta; Neeru Malik; Rakesh Malik; Raman Kumar; Ravneet Kaur; Vinod Bhatt; Ashish Bhalla; Manju Mohanty; Gurmeet Singh; Suresh Kumar Sharma; Madhava Sai Sivapuram; Deepali Mathur; Dibbendu Khanra; Akshay Anand
Journal:  Front Public Health       Date:  2022-06-13

3.  Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study.

Authors:  S S Iyengar; S N Narasingan; Pramod Gandhi; Navneet Jaipuriar; Asha Mahilmaran; Sachin Patil; Mahesh V Abhyankar; Santosh Revankar
Journal:  J Family Med Prim Care       Date:  2020-08-25

4.  Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected.

Authors:  Nitika Setia; Renu Saxena; J P S Sawhney; Ishwar C Verma
Journal:  Indian J Pediatr       Date:  2018-02-15       Impact factor: 1.967

5.  Prevalence of statin use among high-risk patients in urban and rural Vellore, Tamil Nadu: A population-based cross-sectional study.

Authors:  Anu Mary Oommen; Khushboo Nand; Vinod Joseph Abraham; Kuryan George; V Jacob Jose
Journal:  Indian J Pharmacol       Date:  2017 Mar-Apr       Impact factor: 1.200

Review 6.  Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.

Authors:  Sanjay Kalra; Zhenyue Chen; Chaicharn Deerochanawong; Kou-Gi Shyu; Ru San Tan; Brian Tomlinson; Hung-I Yeh
Journal:  J Atheroscler Thromb       Date:  2021-03-19       Impact factor: 4.928

Review 7.  Risk Factors Analysis and Management of Cardiometabolic-Based Chronic Disease in Low- and Middle-Income Countries.

Authors:  Chaitanya Dutt; Joao Eduardo Nunes Salles; Shashank Joshi; Tiny Nair; Subhankar Chowdhury; Ambrish Mithal; Viswanathan Mohan; Ravi Kasliwal; Satyawan Sharma; Jan Tijssen; Nikhil Tandon
Journal:  Diabetes Metab Syndr Obes       Date:  2022-02-16       Impact factor: 3.168

Review 8.  Have we reached the bottom of the bottomless pit- lessons from the recent lipid-lowering trials?

Authors:  Manish Bansal; Rajeev Agarwala
Journal:  Indian Heart J       Date:  2018 May - Jun

9.  Is evaluation of non-HDL-C better than calculated LDL-C in CAD patients? MMIMSR experiences.

Authors:  Gobardhan Kathariya; Jyoti Aggarwal; Paras Garg; Sonu Singh; Sajaad Manzoor
Journal:  Indian Heart J       Date:  2020-05-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.